# Celularity Inc

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:582dbabe-eda3-4414-a596-3f9e66a31124 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/celularity-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 16 |
| Claims under review | 1 |
| Evidence records | 4 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-28T04:47:22.532914+00:00 |
| Last reviewed | 2026-10-28T04:47:22.532914+00:00 |

## Identity

- Legal name: Celularity Inc
- Display name: Celularity Inc

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-28T22:07:03.602665+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.82 |
| Directors | 3 |
| Committees | 3 |
| Governance events | 4 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Diane Parks: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Audit (member); Compensation (chair). claim_id=alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:leadership_role:5
- Peter H. Diamandis, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (member); Nominating/Governance (chair). claim_id=alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:leadership_role:6
- Robert J. Hariri, M.D., Ph.D.: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:leadership_role:7

## Committees

- Audit (audit). Chair: NOT_PUBLISHED. Members: Diane Parks (member, current). committee_id=alpha:committee:celularity-inc:audit
- Compensation (compensation). Chair: Diane Parks. Members: Diane Parks (chair, current); Peter H. Diamandis, M.D. (member, current). committee_id=alpha:committee:celularity-inc:compensation
- Nominating/Governance (nominating_governance). Chair: Peter H. Diamandis, M.D.. Members: Peter H. Diamandis, M.D. (chair, current). committee_id=alpha:committee:celularity-inc:nominating-governance

## Executive leadership

- Robert J. Hariri, M.D., Ph.D.: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:leadership_role:8

## Governance events

- CEO_CHANGED: Robert J. Hariri, M.D., Ph.D. executive of Celularity Inc, effective 2025-11-07. Effective: 2025-11-07. Detected: 2026-10-28T04:47:22.532914+00:00. event_id=alpha:event:transition:rtss4g17vxka0
- DIRECTOR_APPOINTED: Diane Parks seat on Celularity Inc, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-28T04:47:22.532914+00:00. event_id=alpha:event:transition:zlud8qso4dwo
- DIRECTOR_APPOINTED: Peter H. Diamandis, M.D. seat on Celularity Inc, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-28T04:47:22.532914+00:00. event_id=alpha:event:transition:1vtmjxm1w7t900
- DIRECTOR_APPOINTED: Robert J. Hariri, M.D., Ph.D. seat on Celularity Inc, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-28T04:47:22.532914+00:00. event_id=alpha:event:transition:1upsx8v1q6k3kp

## Scoped resources

- `alpha://company/celularity-inc` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record
- `alpha://company/celularity-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=identity
- `alpha://company/celularity-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=corporate-structure
- `alpha://company/celularity-inc/board` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=board
- `alpha://company/celularity-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=committees
- `alpha://company/celularity-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=leadership
- `alpha://company/celularity-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=ownership
- `alpha://company/celularity-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=financials
- `alpha://company/celularity-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=capital-structure
- `alpha://company/celularity-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=compensation
- `alpha://company/celularity-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=governance
- `alpha://company/celularity-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=shareholder-governance
- `alpha://company/celularity-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=audit
- `alpha://company/celularity-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=legal
- `alpha://company/celularity-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=risk
- `alpha://company/celularity-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=cyber
- `alpha://company/celularity-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=ai-governance
- `alpha://company/celularity-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=agents
- `alpha://company/celularity-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=ecosystem
- `alpha://company/celularity-inc/events` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=events
- `alpha://company/celularity-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=relationships
- `alpha://company/celularity-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=assessments
- `alpha://company/celularity-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/celularity-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:committee_appointment:10: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:diane-parks","name":"Diane Parks"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:committee_appointment:12: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:diane-parks","name":"Diane Parks"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:committee_appointment:13: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:peter-h-diamandis-m-d","name":"Peter H. Diamandis, M.D."},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Nominating/Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:peter-h-diamandis-m-d","name":"Peter H. Diamandis, M.D."},"source_id":"governance_people_committees"}`

## Leadership

- Diane Parks: Director. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:leadership_role:5. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9e38685019791b784ad0a5b1026a759a9f59d1789048498d08cb206c93adda4a.
- Peter H. Diamandis, M.D.: Director. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9e38685019791b784ad0a5b1026a759a9f59d1789048498d08cb206c93adda4a.
- Robert J. Hariri, M.D., Ph.D.: Director. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:leadership_role:7. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9e38685019791b784ad0a5b1026a759a9f59d1789048498d08cb206c93adda4a.
- Robert J. Hariri, M.D., Ph.D.: Chief Executive Officer. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:leadership_role:8. Valid from: 2025-11-07. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ad0cbf5ba58489cf87a7293f50a5915612d9b6200acb0f71308a98b570ac79a.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit: Chair not stated; Members Diane Parks. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:committee_record:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd9a3eea91bd343223297dc5a31a1c2b54332a792f92363912f9ef1555e0b3e3.
- Compensation: Chair Diane Parks; Members Diane Parks (Chair); Peter H. Diamandis, M.D.. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:committee_record:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd9a3eea91bd343223297dc5a31a1c2b54332a792f92363912f9ef1555e0b3e3.
- Nominating/Governance: Chair Peter H. Diamandis, M.D.; Members Peter H. Diamandis, M.D. (Chair). Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:committee_record:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd9a3eea91bd343223297dc5a31a1c2b54332a792f92363912f9ef1555e0b3e3.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Celularity Inc. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f71b1b5b091d40f2c5f1b3d9e59c2f76a94e514f76a0a54c29475a702f1e77c3.

## Entity Status

- Public listing published. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f71b1b5b091d40f2c5f1b3d9e59c2f76a94e514f76a0a54c29475a702f1e77c3.

## Published Fact

- US. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f71b1b5b091d40f2c5f1b3d9e59c2f76a94e514f76a0a54c29475a702f1e77c3.

## Committee Appointment

- Diane Parks: member, Audit. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:committee_appointment:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd9a3eea91bd343223297dc5a31a1c2b54332a792f92363912f9ef1555e0b3e3.
- Diane Parks: chair, Compensation. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:committee_appointment:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd9a3eea91bd343223297dc5a31a1c2b54332a792f92363912f9ef1555e0b3e3.
- Peter H. Diamandis, M.D.: member, Compensation. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:committee_appointment:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd9a3eea91bd343223297dc5a31a1c2b54332a792f92363912f9ef1555e0b3e3.
- Peter H. Diamandis, M.D.: chair, Nominating/Governance. Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd9a3eea91bd343223297dc5a31a1c2b54332a792f92363912f9ef1555e0b3e3.

## Security Listing

- CELU (NASDAQ). Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:security_listing:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f71b1b5b091d40f2c5f1b3d9e59c2f76a94e514f76a0a54c29475a702f1e77c3.
- CELUW (NASDAQ). Claim: alpha:claim:company:582dbabe-eda3-4414-a596-3f9e66a31124:security_listing:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f71b1b5b091d40f2c5f1b3d9e59c2f76a94e514f76a0a54c29475a702f1e77c3.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:f71b1b5b091d40f2c5f1b3d9e59c2f76a94e514f76a0a54c29475a702f1e77c3: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/celularity-inc).
- alpha:projection-evidence:document:9e38685019791b784ad0a5b1026a759a9f59d1789048498d08cb206c93adda4a: [Celularity Inc DEF 14A 2025-11-07](https://www.sec.gov/Archives/edgar/data/1752828/000149315225021208/formdef14a.htm).
- alpha:projection-evidence:document:8ad0cbf5ba58489cf87a7293f50a5915612d9b6200acb0f71308a98b570ac79a: [CELU DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1752828/000149315225021208/formdef14a.htm).
- alpha:projection-evidence:bd9a3eea91bd343223297dc5a31a1c2b54332a792f92363912f9ef1555e0b3e3: [Audit](https://www.sec.gov/Archives/edgar/data/1752828/000149315225021208/formdef14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/celularity-inc)
- [Public Markdown](https://registry.alpha.ac/companies/celularity-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/celularity-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/celularity-inc?format=jsonld)
- MCP resource: `alpha://companies/celularity-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-28T22:07:02.907255+00:00; recorded 2026-10-28T22:07:02.907255+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.